Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The national program on standardized cancer care pathways in Sweden: Observations and findings half way through
Socialstyrelsen National Board of Health and Welfare, Department of Evaluation and Analysis, Stockholm, Sweden.
Jönköping University, School of Health and Welfare, The Jönköping Academy for Improvement of Health and Welfare. Jönköping University, School of Health and Welfare, HHJ. IMPROVE (Improvement, innovation, and leadership in health and welfare).ORCID iD: 0000-0003-1814-4478
Linkopings universitet, Department of Management and Engineering, Linkoping, Sweden.
Lunds Universitet, Department of Design Sciences, Lund, Sweden.
Show others and affiliations
2018 (English)In: Health Policy, ISSN 0168-8510, E-ISSN 1872-6054, Vol. 122, no 9, p. 945-948Article in journal (Refereed) Published
Abstract [en]

In 2015, the Swedish government initiated a national cancer reform program to standardize cancer care pathways. Primary aims included shortened waiting times among patients with suspected cancer, increased patient satisfaction and reduced regional variation. The implementation phase of the program is now more than half way through and both achievements and challenges have been identified. The ongoing evaluation demonstrates that professional engagement and adjustments on the meso- and micro-level of the system are essential to achieving sustainable improvements. Waiting times have shortened for the pathways launched first, and patients are satisfied with a more transparent process. Physicians in primary care are satisfied to inform patients about the pathways but point out problems with comorbidity and complicated diagnostic procedures related to unspecific symptoms. Mechanisms and ethical considerations behind possible crowding-out effects need to be thoroughly highlighted and discussed with staff and management. The results so far appear promising but meso- and micro-levels of the system need to be more involved in the design processes.

Place, publisher, year, edition, pages
Elsevier, 2018. Vol. 122, no 9, p. 945-948
Keywords [en]
Cancer care, Microsystem perspective, Primary health care, Standardized pathways
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:hj:diva-41906DOI: 10.1016/j.healthpol.2018.07.012ISI: 000445311500003PubMedID: 30075866Scopus ID: 2-s2.0-85050683269OAI: oai:DiVA.org:hj-41906DiVA, id: diva2:1258918
Available from: 2018-10-26 Created: 2018-10-26 Last updated: 2018-11-02Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records BETA

Thor, Johan

Search in DiVA

By author/editor
Thor, Johan
By organisation
The Jönköping Academy for Improvement of Health and WelfareHHJ. IMPROVE (Improvement, innovation, and leadership in health and welfare)
In the same journal
Health Policy
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 20 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf